![The AllyCon thrive logo.](/sites/default/files/styles/1025x570/public/media/images/thrive-allycon-logo-website.png.webp?itok=za2IpoWM)
Watch session videos from AllyCon 2024
![The AllyCon thrive logo.](/sites/default/files/styles/1025x570/public/media/images/thrive-allycon-logo-website.png.webp?itok=za2IpoWM)
Navigating Your Care Journey
Learn to navigate the cancer care continuum, ask the right questions, balance life during and after treatment, and explore the latest in CRC nutrition — all designed to help you live well with colorectal cancer.
Moderator: Dr. Sharon Stein
Panel: Dr. Larissa Temple, Jenna Scott, Carly Roop, Sean Powell, Dr. Sarah Hoffe & Dr. Eric Christenson
![Screen capture of AllyCon live recording](/sites/default/files/styles/1600x600/public/media/images/allycon-video-live-1.png.webp?itok=QdM8Y2JJ)
Colorectal Cancer State of the Union
Discover advancements shaping cancer care. With expert perspectives on FDA approvals and key Medicare updates, the potential of ctDNA and MRD, and emerging research, this session will leave you empowered and informed.
Moderator: John Woerner
Panel: Dr. Adham Jurdi & Dr. Nilo Azad
![Screen capture of AllyCon live recording](/sites/default/files/styles/1600x600/public/media/images/allycon-video-live-2.png.webp?itok=71ImJCj5)
Stay tuned for more information about the 2025 AllyCon conference.
Top resources
![Poster presentation at ASCO GI](/sites/default/files/styles/450x250/public/media/images/david-asco-poster.png.webp?itok=u-tfKXDI)
Unmet needs in CRC: Survey results offer hope
Uncover key survey findings on the unmet psychosocial and physical needs of colorectal cancer patients and survivors, and learn how the Alliance is shaping better care.
![Hope performing a yoga pose](/sites/default/files/styles/450x250/public/media/images/hope1-edit.png.webp?itok=bHehcyXk)
HAI liver pump for mCRC offers second chances
Discover how Hope overcame stage IV colorectal cancer with an innovative HAI liver pump, staying active and proving that second chances are possible.
![Amgen's headquarters](/sites/default/files/styles/450x250/public/media/images/amgen.png.webp?itok=3N8SUkGc)
Treatment for KRAS G12C-mutated metastatic CRC approved by FDA
The U.S. Food and Drug Administration has approved sotorasib in combination with panitumumab for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer.